Incidence and risk factors for developing venous thromboembolism (VTE) in Japanese patients with diffuse large B-cell lymphoma (DLBCL)

被引：0
|
作者：
Yokoyama, K. [1 ]
Murata, M. [2 ]
Ikeda, Y. [3 ]
Okamoto, S. [1 ]
机构：
[1] Keio Univ, Sch Med, Dept Med, Div Hematol, Tokyo 108, Japan
[2] Keio Univ, Sch Med, Dept Lab Med, Tokyo 108, Japan
[3] Waseda Univ, Grad Sch Adv Sci & Engn, Tokyo, Japan
来源：
JOURNAL OF THROMBOSIS AND HAEMOSTASIS | 2011年 / 9卷
关键词：
D O I：
暂无
中图分类号：
R5 [内科学];
学科分类号：
1002 ; 100201 ;
摘要：
引用
收藏
页码：37 / 38
页数：2
相关论文
共 50 条
  • [41] Examining the Racial Disparities In Presentation and Treatment for Patients with Diffuse Large B-Cell Lymphoma (DLBCL).
    Shenoy, Pareen J.
    Borate, Uma
    Bumpers, Kevin
    Douglas-Holland, Tanyanika
    King, Nassoma
    Lechowicz, Mary Jo
    Jaye, David L.
    Donnellan, Will
    The, Angelina
    Reddy, Vishnu
    Foran, James M.
    Flowers, Christopher R.
    BLOOD, 2010, 116 (21) : 647 - 647
  • [42] Outcome of Adolescent & Young Adult (AYA) Patients with Diffuse Large B-Cell Lymphoma (DLBCL)
    Beck, Jill C.
    Bast, Martin
    Perry, Deborah A.
    Smith, Lynette M.
    Weisenburger, Dennis D.
    BLOOD, 2012, 120 (21)
  • [43] Management Strategies and Outcomes for Very Elderly Patients with Diffuse Large B-Cell Lymphoma (DLBCL)
    Chihara, Dai
    Ahmed, Mohamed Amin
    Oki, Yasuhiro
    Westin, Jason R.
    Hagemeister, Fredrick B.
    Romaguera, Jorge E.
    Fanale, Michelle A.
    Lee, Hun Ju
    Turturro, Francesco
    Samaniego, Felipe
    Neelapu, Sattva S.
    Rodriguez, Alma
    Fowler, Nathan
    Wang, Michael
    Fayad, Luis E.
    Davis, Richard Eric
    Nastoupil, Loretta
    BLOOD, 2015, 126 (23)
  • [44] Racial differences in treatment and survival in older patients with diffuse large B-cell lymphoma (DLBCL)
    Griffiths, Robert
    Gleeson, Michelle
    Knopf, Kevin
    Danese, Mark
    BMC CANCER, 2010, 10
  • [45] CLINICAL FEATURES AND SURVIVAL OF PATIENTS WITH LATE RELAPSED DIFFUSE LARGE B-CELL LYMPHOMA (DLBCL)
    Castillo-Giron, C.
    Rivas-Delgado, A.
    Dlouhy, I
    Rovira, J.
    Mozas, P.
    Rivero, A.
    Frigola, G.
    Balague, O.
    Baumann, T.
    Correa, J. G.
    Magnano, L.
    Jimenez-Vicente, C.
    Gomez, M.
    Delgado, J.
    Villamor, N.
    Campo, E.
    Gine, E.
    Lopez-Guillermo, A.
    HAEMATOLOGICA, 2020, 105 : 291 - 292
  • [46] Identification of novel targets for immunotherapies in subsets of patients with diffuse large B-cell lymphoma (DLBCL)
    Heini, Alexander D.
    Bacher, Ulrike
    Pabst, Thomas
    BRITISH JOURNAL OF HAEMATOLOGY, 2024, 204 (02) : 389 - 390
  • [47] Racial differences in treatment and survival in older patients with diffuse large B-cell lymphoma (DLBCL)
    Robert Griffiths
    Michelle Gleeson
    Kevin Knopf
    Mark Danese
    BMC Cancer, 10
  • [48] Anemia in diffuse large B-cell non-Hodgkin's lymphoma (DLBCL) patients
    Gallagher, C. L.
    Glinert, K. D.
    Kohut, I. F.
    Henry, D. H.
    JOURNAL OF CLINICAL ONCOLOGY, 2010, 28 (15)
  • [49] Mean platelet volume as a predictive marker for venous thromboembolism and mortality in patients treated for diffuse large B-cell lymphoma
    Rupa-Matysek, Joanna
    Gil, Lidia
    Kroll-Balcerzak, Renata
    Baranska, Marta
    Komarnicki, Mieczyslaw
    HEMATOLOGICAL ONCOLOGY, 2017, 35 (04) : 456 - 464
  • [50] Cell of Origin of Diffuse Large B-Cell Lymphoma (DLBCL) in Patients with Systemic Lupus Erythematosus (SLE)
    Cloutier, Basile Tessier
    Farinha, Pedro
    Bernatsky, Sasha
    Baecklund, Eva
    Clarke, Ann E.
    Ramsey-Goldman, Rosalind
    Gascoyne, Randy
    ARTHRITIS & RHEUMATOLOGY, 2015, 67
12345